Weather threats to drug production facilities examined in study
A JAMA study published Aug. 20 found that nearly 63% of all U.S. drug production facilities from 2019 through 2024 were in counties where a weather disaster declaration was declared. About 34% of facilities were in such areas annually during the study period. Researchers said the findings demonstrate an urgent need for supply chain transparency, strategic allocation of production, and disaster risk management strategies to prevent future health care disruptions in the U.S.
Related News Articles
Headline
The U.S. Trade Representative yesterday announced it is implementing a 10% or 12.5% tariff on 60 trading partners, which became effective today. These…
Headline
The Centers for Medicare & Medicaid Services, the Centers for Disease Control and Prevention, and the Department of Health and Human Services July 15…
Headline
The Food and Drug Administration July 10 released a proposed rule that would modernize drug establishment registration requirements, with implications for…
Headline
The AHA today sent a letter to the Office of the United States Trade Representative to ask that medications, medical devices and other healthcare…
Headline
Angela Hewlett, M.D., professor of infectious diseases at the University of Nebraska Medical Center and medical director of the Nebraska Biocontainment Unit,…
Headline
The Food and Drug Administration June 16 announced that a nationwide shortage of stereotactic breast biopsy needles is expected to last through the end of…